Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group

NCT07476729 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT07476729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07476729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2033
Enrollment
750 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukaemia